Swedish Pharmaceuticals & Biotech Nano Cap Stocks

Moberg Pharma

Market Cap: SEK 430.5m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Oncopeptides

Market Cap: SEK 343.2m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

Corline Biomedical

Market Cap: SEK 242.0m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Biosergen

Market Cap: SEK 149.3m

A biotech company, develops antifungal products.

Biovica International

Market Cap: SEK 74.7m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.

Modus Therapeutics Holding

Market Cap: SEK 53.5m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

Sprint Bioscience

Market Cap: SEK 44.3m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

Double Bond Pharmaceutical International

Market Cap: SEK 27.5m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.